Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
The Pune centre expands its presence beyond Bangalore and Hyderabad
Fastminar is a 40-feet structure made with approximately 80,000 toothbrushes and is located at Terna Dental College in Navi Mumbai
HTL will build, validate and operate a botulinum manufacturing facility in the US
XELJANZ is the first and only Janus kinase (JAK) inhibitor approved in Europe for the treatment of polyarticular JIA and juvenile PsA and has received regulatory approval in four indications in the European Union, the most of any JAK inhibitor
Subscribe To Our Newsletter & Stay Updated
